img

Global CD147 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global CD147 Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

CD147 Antibody report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global CD147 Antibody market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Immunochemistry (IHC) and Immunofluorescence (IF) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for CD147 Antibody industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, CD147 Antibody key manufacturers include BosterBio, Bioss, BD Biosciences, GeneTex, RayBiotech, Bio-Rad, NSJ Bioreagents, BioLegend and Abcam, etc. BosterBio, Bioss, BD Biosciences are top 3 players and held % sales share in total in 2022.
CD147 Antibody can be divided into Monoclonal and Polyclonal, etc. Monoclonal is the mainstream product in the market, accounting for % sales share globally in 2022.
CD147 Antibody is widely used in various fields, such as Immunochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP) and Western Blot (WB), etc. Immunochemistry (IHC) provides greatest supports to the CD147 Antibody industry development. In 2022, global % sales of CD147 Antibody went into Immunochemistry (IHC) filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global CD147 Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


BosterBio
Bioss
BD Biosciences
GeneTex
RayBiotech
Bio-Rad
NSJ Bioreagents
BioLegend
Abcam
Cell Sciences
LifeSpan BioSciences
Bethyl Laboratories
HUABIO
Thermo Fisher Scientific
Novus Biologicals
Elabscience Biotechnology
R&D Systems
Miltenyi Biotec
Biobyt
Jingjie PTM BioLab
Segment by Type
Monoclonal
Polyclonal

Segment by Application


Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the CD147 Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of CD147 Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the CD147 Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2023-2033) volume and revenue analysis of CD147 Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, CD147 Antibody introduction, etc. CD147 Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13MRAResearch’s Conclusions of CD147 Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 CD147 Antibody Market Overview
1.1 CD147 Antibody Product Overview
1.2 CD147 Antibody Market Segment by Type
1.2.1 Monoclonal
1.2.2 Polyclonal
1.3 Global CD147 Antibody Market Size by Type
1.3.1 Global CD147 Antibody Market Size Overview by Type (2018-2033)
1.3.2 Global CD147 Antibody Historic Market Size Review by Type (2018-2023)
1.3.3 Global CD147 Antibody Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America CD147 Antibody Sales Breakdown by Type (2018-2023)
1.4.2 Europe CD147 Antibody Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific CD147 Antibody Sales Breakdown by Type (2018-2023)
1.4.4 Latin America CD147 Antibody Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa CD147 Antibody Sales Breakdown by Type (2018-2023)
2 Global CD147 Antibody Market Competition by Company
2.1 Global Top Players by CD147 Antibody Sales (2018-2023)
2.2 Global Top Players by CD147 Antibody Revenue (2018-2023)
2.3 Global Top Players by CD147 Antibody Price (2018-2023)
2.4 Global Top Manufacturers CD147 Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 CD147 Antibody Market Competitive Situation and Trends
2.5.1 CD147 Antibody Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by CD147 Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CD147 Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into CD147 Antibody Market
2.8 Key Manufacturers CD147 Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 CD147 Antibody Status and Outlook by Region
3.1 Global CD147 Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global CD147 Antibody Historic Market Size by Region
3.2.1 Global CD147 Antibody Sales in Volume by Region (2018-2023)
3.2.2 Global CD147 Antibody Sales in Value by Region (2018-2023)
3.2.3 Global CD147 Antibody Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global CD147 Antibody Forecasted Market Size by Region
3.3.1 Global CD147 Antibody Sales in Volume by Region (2024-2033)
3.3.2 Global CD147 Antibody Sales in Value by Region (2024-2033)
3.3.3 Global CD147 Antibody Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global CD147 Antibody by Application
4.1 CD147 Antibody Market Segment by Application
4.1.1 Immunochemistry (IHC)
4.1.2 Immunofluorescence (IF)
4.1.3 Immunoprecipitation (IP)
4.1.4 Western Blot (WB)
4.1.5 ELISA
4.1.6 Others
4.2 Global CD147 Antibody Market Size by Application
4.2.1 Global CD147 Antibody Market Size Overview by Application (2018-2033)
4.2.2 Global CD147 Antibody Historic Market Size Review by Application (2018-2023)
4.2.3 Global CD147 Antibody Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America CD147 Antibody Sales Breakdown by Application (2018-2023)
4.3.2 Europe CD147 Antibody Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific CD147 Antibody Sales Breakdown by Application (2018-2023)
4.3.4 Latin America CD147 Antibody Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa CD147 Antibody Sales Breakdown by Application (2018-2023)
5 North America CD147 Antibody by Country
5.1 North America CD147 Antibody Historic Market Size by Country
5.1.1 North America CD147 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America CD147 Antibody Sales in Volume by Country (2018-2023)
5.1.3 North America CD147 Antibody Sales in Value by Country (2018-2023)
5.2 North America CD147 Antibody Forecasted Market Size by Country
5.2.1 North America CD147 Antibody Sales in Volume by Country (2024-2033)
5.2.2 North America CD147 Antibody Sales in Value by Country (2024-2033)
6 Europe CD147 Antibody by Country
6.1 Europe CD147 Antibody Historic Market Size by Country
6.1.1 Europe CD147 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe CD147 Antibody Sales in Volume by Country (2018-2023)
6.1.3 Europe CD147 Antibody Sales in Value by Country (2018-2023)
6.2 Europe CD147 Antibody Forecasted Market Size by Country
6.2.1 Europe CD147 Antibody Sales in Volume by Country (2024-2033)
6.2.2 Europe CD147 Antibody Sales in Value by Country (2024-2033)
7 Asia-Pacific CD147 Antibody by Region
7.1 Asia-Pacific CD147 Antibody Historic Market Size by Region
7.1.1 Asia-Pacific CD147 Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific CD147 Antibody Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific CD147 Antibody Sales in Value by Region (2018-2023)
7.2 Asia-Pacific CD147 Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific CD147 Antibody Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific CD147 Antibody Sales in Value by Region (2024-2033)
8 Latin America CD147 Antibody by Country
8.1 Latin America CD147 Antibody Historic Market Size by Country
8.1.1 Latin America CD147 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America CD147 Antibody Sales in Volume by Country (2018-2023)
8.1.3 Latin America CD147 Antibody Sales in Value by Country (2018-2023)
8.2 Latin America CD147 Antibody Forecasted Market Size by Country
8.2.1 Latin America CD147 Antibody Sales in Volume by Country (2024-2033)
8.2.2 Latin America CD147 Antibody Sales in Value by Country (2024-2033)
9 Middle East and Africa CD147 Antibody by Country
9.1 Middle East and Africa CD147 Antibody Historic Market Size by Country
9.1.1 Middle East and Africa CD147 Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa CD147 Antibody Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa CD147 Antibody Sales in Value by Country (2018-2023)
9.2 Middle East and Africa CD147 Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa CD147 Antibody Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa CD147 Antibody Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 BosterBio
10.1.1 BosterBio Company Information
10.1.2 BosterBio Introduction and Business Overview
10.1.3 BosterBio CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BosterBio CD147 Antibody Products Offered
10.1.5 BosterBio Recent Development
10.2 Bioss
10.2.1 Bioss Company Information
10.2.2 Bioss Introduction and Business Overview
10.2.3 Bioss CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bioss CD147 Antibody Products Offered
10.2.5 Bioss Recent Development
10.3 BD Biosciences
10.3.1 BD Biosciences Company Information
10.3.2 BD Biosciences Introduction and Business Overview
10.3.3 BD Biosciences CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BD Biosciences CD147 Antibody Products Offered
10.3.5 BD Biosciences Recent Development
10.4 GeneTex
10.4.1 GeneTex Company Information
10.4.2 GeneTex Introduction and Business Overview
10.4.3 GeneTex CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GeneTex CD147 Antibody Products Offered
10.4.5 GeneTex Recent Development
10.5 RayBiotech
10.5.1 RayBiotech Company Information
10.5.2 RayBiotech Introduction and Business Overview
10.5.3 RayBiotech CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.5.4 RayBiotech CD147 Antibody Products Offered
10.5.5 RayBiotech Recent Development
10.6 Bio-Rad
10.6.1 Bio-Rad Company Information
10.6.2 Bio-Rad Introduction and Business Overview
10.6.3 Bio-Rad CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bio-Rad CD147 Antibody Products Offered
10.6.5 Bio-Rad Recent Development
10.7 NSJ Bioreagents
10.7.1 NSJ Bioreagents Company Information
10.7.2 NSJ Bioreagents Introduction and Business Overview
10.7.3 NSJ Bioreagents CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.7.4 NSJ Bioreagents CD147 Antibody Products Offered
10.7.5 NSJ Bioreagents Recent Development
10.8 BioLegend
10.8.1 BioLegend Company Information
10.8.2 BioLegend Introduction and Business Overview
10.8.3 BioLegend CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.8.4 BioLegend CD147 Antibody Products Offered
10.8.5 BioLegend Recent Development
10.9 Abcam
10.9.1 Abcam Company Information
10.9.2 Abcam Introduction and Business Overview
10.9.3 Abcam CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Abcam CD147 Antibody Products Offered
10.9.5 Abcam Recent Development
10.10 Cell Sciences
10.10.1 Cell Sciences Company Information
10.10.2 Cell Sciences Introduction and Business Overview
10.10.3 Cell Sciences CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Cell Sciences CD147 Antibody Products Offered
10.10.5 Cell Sciences Recent Development
10.11 LifeSpan BioSciences
10.11.1 LifeSpan BioSciences Company Information
10.11.2 LifeSpan BioSciences Introduction and Business Overview
10.11.3 LifeSpan BioSciences CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.11.4 LifeSpan BioSciences CD147 Antibody Products Offered
10.11.5 LifeSpan BioSciences Recent Development
10.12 Bethyl Laboratories
10.12.1 Bethyl Laboratories Company Information
10.12.2 Bethyl Laboratories Introduction and Business Overview
10.12.3 Bethyl Laboratories CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Bethyl Laboratories CD147 Antibody Products Offered
10.12.5 Bethyl Laboratories Recent Development
10.13 HUABIO
10.13.1 HUABIO Company Information
10.13.2 HUABIO Introduction and Business Overview
10.13.3 HUABIO CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.13.4 HUABIO CD147 Antibody Products Offered
10.13.5 HUABIO Recent Development
10.14 Thermo Fisher Scientific
10.14.1 Thermo Fisher Scientific Company Information
10.14.2 Thermo Fisher Scientific Introduction and Business Overview
10.14.3 Thermo Fisher Scientific CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Thermo Fisher Scientific CD147 Antibody Products Offered
10.14.5 Thermo Fisher Scientific Recent Development
10.15 Novus Biologicals
10.15.1 Novus Biologicals Company Information
10.15.2 Novus Biologicals Introduction and Business Overview
10.15.3 Novus Biologicals CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Novus Biologicals CD147 Antibody Products Offered
10.15.5 Novus Biologicals Recent Development
10.16 Elabscience Biotechnology
10.16.1 Elabscience Biotechnology Company Information
10.16.2 Elabscience Biotechnology Introduction and Business Overview
10.16.3 Elabscience Biotechnology CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Elabscience Biotechnology CD147 Antibody Products Offered
10.16.5 Elabscience Biotechnology Recent Development
10.17 R&D Systems
10.17.1 R&D Systems Company Information
10.17.2 R&D Systems Introduction and Business Overview
10.17.3 R&D Systems CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.17.4 R&D Systems CD147 Antibody Products Offered
10.17.5 R&D Systems Recent Development
10.18 Miltenyi Biotec
10.18.1 Miltenyi Biotec Company Information
10.18.2 Miltenyi Biotec Introduction and Business Overview
10.18.3 Miltenyi Biotec CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Miltenyi Biotec CD147 Antibody Products Offered
10.18.5 Miltenyi Biotec Recent Development
10.19 Biobyt
10.19.1 Biobyt Company Information
10.19.2 Biobyt Introduction and Business Overview
10.19.3 Biobyt CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Biobyt CD147 Antibody Products Offered
10.19.5 Biobyt Recent Development
10.20 Jingjie PTM BioLab
10.20.1 Jingjie PTM BioLab Company Information
10.20.2 Jingjie PTM BioLab Introduction and Business Overview
10.20.3 Jingjie PTM BioLab CD147 Antibody Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Jingjie PTM BioLab CD147 Antibody Products Offered
10.20.5 Jingjie PTM BioLab Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 CD147 Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 CD147 Antibody Industrial Chain Analysis
11.4 CD147 Antibody Market Dynamics
11.4.1 CD147 Antibody Industry Trends
11.4.2 CD147 Antibody Market Drivers
11.4.3 CD147 Antibody Market Challenges
11.4.4 CD147 Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 CD147 Antibody Distributors
12.3 CD147 Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal
Table 2. Major Company of Polyclonal
Table 3. Global CD147 Antibody Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 4. Global CD147 Antibody Sales by Type (2018-2023) & (ml)
Table 5. Global CD147 Antibody Sales Market Share in Volume by Type (2018-2023)
Table 6. Global CD147 Antibody Sales by Type (2018-2023) & (US& Million)
Table 7. Global CD147 Antibody Market Share in Value by Type (2018-2023)
Table 8. Global CD147 Antibody Price by Type (2018-2023) & (US$/ml)
Table 9. Global CD147 Antibody Sales by Type (2024-2033) & (ml)
Table 10. Global CD147 Antibody Sales Market Share in Volume by Type (2024-2033)
Table 11. Global CD147 Antibody Sales by Type (2024-2033) & (US$ Million)
Table 12. Global CD147 Antibody Sales Market Share in Value by Type (2024-2033)
Table 13. Global CD147 Antibody Price by Type (2024-2033) & (US$/ml)
Table 14. North America CD147 Antibody Sales by Type (2018-2023) & (ml)
Table 15. North America CD147 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe CD147 Antibody Sales (ml) by Type (2018-2023)
Table 17. Europe CD147 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific CD147 Antibody Sales (ml) by Type (2018-2023)
Table 19. Asia-Pacific CD147 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America CD147 Antibody Sales (ml) by Type (2018-2023)
Table 21. Latin America CD147 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa CD147 Antibody Sales (ml) by Type (2018-2023)
Table 23. Middle East and Africa CD147 Antibody Sales by Type (2018-2023) & (US$ Million)
Table 24. Global CD147 Antibody Sales by Company (2018-2023) & (ml)
Table 25. Global CD147 Antibody Sales Share by Company (2018-2023)
Table 26. Global CD147 Antibody Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global CD147 Antibody Revenue Share by Company (2018-2023)
Table 28. Global Market CD147 Antibody Price by Company (2018-2023) & (US$/ml)
Table 29. Global CD147 Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global CD147 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CD147 Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into CD147 Antibody Market
Table 33. Key Manufacturers CD147 Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global CD147 Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 36. Global CD147 Antibody Sales by Region (2018-2023) & (ml)
Table 37. Global CD147 Antibody Sales Market Share in Volume by Region (2018-2023)
Table 38. Global CD147 Antibody Sales by Region (2018-2023) & (US$ Million)
Table 39. Global CD147 Antibody Sales Market Share in Value by Region (2018-2023)
Table 40. Global CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 41. Global CD147 Antibody Sales by Region (2024-2033) & (ml)
Table 42. Global CD147 Antibody Sales Market Share in Volume by Region (2024-2033)
Table 43. Global CD147 Antibody Sales by Region (2024-2033) & (US$ Million)
Table 44. Global CD147 Antibody Sales Market Share in Value by Region (2024-2033)
Table 45. Global CD147 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2024-2033)
Table 46. Global CD147 Antibody Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 47. Global CD147 Antibody Sales by Application (2018-2023) & (ml)
Table 48. Global CD147 Antibody Sales Market Share in Volume by Application (2018-2023)
Table 49. Global CD147 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 50. Global CD147 Antibody Sales Market Share in Value by Application (2018-2023)
Table 51. Global CD147 Antibody Price by Application (2018-2023) & (US$/ml)
Table 52. Global CD147 Antibody Sales by Application (2024-2033) & (ml)
Table 53. Global CD147 Antibody Sales Market Share in Volume by Application (2024-2033)
Table 54. Global CD147 Antibody Sales by Application (2024-2033) & (US$ Million)
Table 55. Global CD147 Antibody Sales Market Share in Value by Application (2024-2033)
Table 56. Global CD147 Antibody Price by Application (2024-2033) & (US$/ml)
Table 57. North America CD147 Antibody Sales by Application (2018-2023) (ml)
Table 58. North America CD147 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe CD147 Antibody Sales by Application (2018-2023) (ml)
Table 60. Europe CD147 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific CD147 Antibody Sales by Application (2018-2023) (ml)
Table 62. Asia-Pacific CD147 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America CD147 Antibody Sales by Application (2018-2023) (ml)
Table 64. Latin America CD147 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa CD147 Antibody Sales by Application (2018-2023) (ml)
Table 66. Middle East and Africa CD147 Antibody Sales by Application (2018-2023) & (US$ Million)
Table 67. North America CD147 Antibody Sales by Country (2018-2023) & (ml)
Table 68. North America CD147 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 69. North America CD147 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 70. North America CD147 Antibody Sales Market Share in Value by Country (2018-2023)
Table 71. North America CD147 Antibody Sales by Country (2024-2033) & (ml)
Table 72. North America CD147 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 73. North America CD147 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 74. North America CD147 Antibody Sales Market Share in Value by Country (2024-2033)
Table 75. Europe CD147 Antibody Sales by Country (2018-2023) & (ml)
Table 76. Europe CD147 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe CD147 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe CD147 Antibody Sales Market Share in Value by Country (2018-2023)
Table 79. Europe CD147 Antibody Sales by Country (2024-2033) & (ml)
Table 80. Europe CD147 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 81. Europe CD147 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 82. Europe CD147 Antibody Sales Market Share in Value by Country (2024-2033)
Table 83. Asia-Pacific CD147 Antibody Sales by Region (2018-2023) & (ml)
Table 84. Asia-Pacific CD147 Antibody Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific CD147 Antibody Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific CD147 Antibody Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific CD147 Antibody Sales by Region (2024-2033) & (ml)
Table 88. Asia-Pacific CD147 Antibody Sales Market Share in Volume by Region (2024-2033)
Table 89. Asia-Pacific CD147 Antibody Sales by Region (2024-2033) & (US$ Million)
Table 90. Asia-Pacific CD147 Antibody Sales Market Share in Value by Region (2024-2033)
Table 91. Latin America CD147 Antibody Sales by Country (2018-2023) & (ml)
Table 92. Latin America CD147 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America CD147 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America CD147 Antibody Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America CD147 Antibody Sales by Country (2024-2033) & (ml)
Table 96. Latin America CD147 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 97. Latin America CD147 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 98. Latin America CD147 Antibody Sales Market Share in Value by Country (2024-2033)
Table 99. Middle East and Africa CD147 Antibody Sales by Country (2018-2023) & (ml)
Table 100. Middle East and Africa CD147 Antibody Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa CD147 Antibody Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa CD147 Antibody Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa CD147 Antibody Sales by Country (2024-2033) & (ml)
Table 104. Middle East and Africa CD147 Antibody Sales Market Share in Volume by Country (2024-2033)
Table 105. Middle East and Africa CD147 Antibody Sales by Country (2024-2033) & (US$ Million)
Table 106. Middle East and Africa CD147 Antibody Sales Market Share in Value by Country (2024-2033)
Table 107. BosterBio Company Information
Table 108. BosterBio Introduction and Business Overview
Table 109. BosterBio CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 110. BosterBio CD147 Antibody Product
Table 111. BosterBio Recent Development
Table 112. Bioss Company Information
Table 113. Bioss Introduction and Business Overview
Table 114. Bioss CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 115. Bioss CD147 Antibody Product
Table 116. Bioss Recent Development
Table 117. BD Biosciences Company Information
Table 118. BD Biosciences Introduction and Business Overview
Table 119. BD Biosciences CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 120. BD Biosciences CD147 Antibody Product
Table 121. BD Biosciences Recent Development
Table 122. GeneTex Company Information
Table 123. GeneTex Introduction and Business Overview
Table 124. GeneTex CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 125. GeneTex CD147 Antibody Product
Table 126. GeneTex Recent Development
Table 127. RayBiotech Company Information
Table 128. RayBiotech Introduction and Business Overview
Table 129. RayBiotech CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 130. RayBiotech CD147 Antibody Product
Table 131. RayBiotech Recent Development
Table 132. Bio-Rad Company Information
Table 133. Bio-Rad Introduction and Business Overview
Table 134. Bio-Rad CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 135. Bio-Rad CD147 Antibody Product
Table 136. Bio-Rad Recent Development
Table 137. NSJ Bioreagents Company Information
Table 138. NSJ Bioreagents Introduction and Business Overview
Table 139. NSJ Bioreagents CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 140. NSJ Bioreagents CD147 Antibody Product
Table 141. NSJ Bioreagents Recent Development
Table 142. BioLegend Company Information
Table 143. BioLegend Introduction and Business Overview
Table 144. BioLegend CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 145. BioLegend CD147 Antibody Product
Table 146. BioLegend Recent Development
Table 147. Abcam Company Information
Table 148. Abcam Introduction and Business Overview
Table 149. Abcam CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 150. Abcam CD147 Antibody Product
Table 151. Abcam Recent Development
Table 152. Cell Sciences Company Information
Table 153. Cell Sciences Introduction and Business Overview
Table 154. Cell Sciences CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 155. Cell Sciences CD147 Antibody Product
Table 156. Cell Sciences Recent Development
Table 157. LifeSpan BioSciences Company Information
Table 158. LifeSpan BioSciences Introduction and Business Overview
Table 159. LifeSpan BioSciences CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 160. LifeSpan BioSciences CD147 Antibody Product
Table 161. LifeSpan BioSciences Recent Development
Table 162. Bethyl Laboratories Company Information
Table 163. Bethyl Laboratories Introduction and Business Overview
Table 164. Bethyl Laboratories CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 165. Bethyl Laboratories CD147 Antibody Product
Table 166. Bethyl Laboratories Recent Development
Table 167. HUABIO Company Information
Table 168. HUABIO Introduction and Business Overview
Table 169. HUABIO CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 170. HUABIO CD147 Antibody Product
Table 171. HUABIO Recent Development
Table 172. Thermo Fisher Scientific Company Information
Table 173. Thermo Fisher Scientific Introduction and Business Overview
Table 174. Thermo Fisher Scientific CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 175. Thermo Fisher Scientific CD147 Antibody Product
Table 176. Thermo Fisher Scientific Recent Development
Table 177. Novus Biologicals Company Information
Table 178. Novus Biologicals Introduction and Business Overview
Table 179. Novus Biologicals CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 180. Novus Biologicals CD147 Antibody Product
Table 181. Novus Biologicals Recent Development
Table 182. Elabscience Biotechnology Company Information
Table 183. Elabscience Biotechnology Introduction and Business Overview
Table 184. Elabscience Biotechnology CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 185. Elabscience Biotechnology CD147 Antibody Product
Table 186. Elabscience Biotechnology Recent Development
Table 187. R&D Systems Company Information
Table 188. R&D Systems Introduction and Business Overview
Table 189. R&D Systems CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 190. R&D Systems CD147 Antibody Product
Table 191. R&D Systems Recent Development
Table 192. Miltenyi Biotec Company Information
Table 193. Miltenyi Biotec Introduction and Business Overview
Table 194. Miltenyi Biotec CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 195. Miltenyi Biotec CD147 Antibody Product
Table 196. Miltenyi Biotec Recent Development
Table 197. Biobyt Company Information
Table 198. Biobyt Introduction and Business Overview
Table 199. Biobyt CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 200. Biobyt CD147 Antibody Product
Table 201. Biobyt Recent Development
Table 202. Jingjie PTM BioLab Company Information
Table 203. Jingjie PTM BioLab Introduction and Business Overview
Table 204. Jingjie PTM BioLab CD147 Antibody Sales (ml), Revenue (Million USD), Price (US$/ml) and Gross Margin (2018-2023)
Table 205. Jingjie PTM BioLab CD147 Antibody Product
Table 206. Jingjie PTM BioLab Recent Development
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. CD147 Antibody Market Trends
Table 210. CD147 Antibody Market Drivers
Table 211. CD147 Antibody Market Challenges
Table 212. CD147 Antibody Market Restraints
Table 213. CD147 Antibody Distributors List
Table 214. CD147 Antibody Downstream Customers
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. CD147 Antibody Product Picture
Figure 2. Global CD147 Antibody Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global CD147 Antibody Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global CD147 Antibody Sales Status and Outlook (2018-2033) & (ml)
Figure 5. Product Picture of Monoclonal
Figure 6. Global Monoclonal Sales YoY Growth (2018-2033) & (ml)
Figure 7. Product Picture of Polyclonal
Figure 8. Global Polyclonal Sales YoY Growth (2018-2033) & (ml)
Figure 9. Global CD147 Antibody Sales by Type (2018-2033) & (US$ Million)
Figure 10. Global CD147 Antibody Sales Market Share by Type in 2022 & 2033
Figure 11. North America CD147 Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America CD147 Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe CD147 Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe CD147 Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific CD147 Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific CD147 Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America CD147 Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America CD147 Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa CD147 Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa CD147 Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by CD147 Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by CD147 Antibody Revenue in 2022
Figure 23. CD147 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Immunochemistry (IHC)
Figure 25. Global Immunochemistry (IHC) Sales YoY Growth (2018-2033) & (ml)
Figure 26. Product Picture of Immunofluorescence (IF)
Figure 27. Global Immunofluorescence (IF) Sales YoY Growth (2018-2033) & (ml)
Figure 28. Product Picture of Immunoprecipitation (IP)
Figure 29. Global Immunoprecipitation (IP) Sales YoY Growth (2018-2033) & (ml)
Figure 30. Product Picture of Western Blot (WB)
Figure 31. Global Western Blot (WB) Sales YoY Growth (2018-2033) & (ml)
Figure 32. Product Picture of ELISA
Figure 33. Global ELISA Sales YoY Growth (2018-2033) & (ml)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2033) & (ml)
Figure 36. Global CD147 Antibody Sales by Application (2018-2033) & (US$ Million)
Figure 37. Global CD147 Antibody Sales Market Share by Application in 2022 & 2033
Figure 38. North America CD147 Antibody Sales Market Share in Volume by Application in 2022
Figure 39. North America CD147 Antibody Sales Market Share in Value by Application in 2022
Figure 40. Europe CD147 Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Europe CD147 Antibody Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific CD147 Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific CD147 Antibody Sales Market Share in Value by Application in 2022
Figure 44. Latin America CD147 Antibody Sales Market Share in Volume by Application in 2022
Figure 45. Latin America CD147 Antibody Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa CD147 Antibody Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. CD147 Antibody Manufacturing Cost Structure
Figure 49. CD147 Antibody Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed